Literature DB >> 23122036

Prostate cancer imaging: what the urologist wants to know.

Saman Shafaat Talab1, Mark A Preston, Azadeh Elmi, Shahin Tabatabaei.   

Abstract

No consensus exists at present regarding the use of imaging for the evaluation of prostate cancer. Ultrasonography is mainly used for biopsy guidance and magnetic resonance imaging is the mainstay in evaluating the extent of local tumor. Computed tomography and radionuclide bone scanning are mainly reserved for assessment of advanced disease. Positron emission tomography is gaining acceptance in the evaluation of treatment response and recurrence. The combination of anatomic, functional, and metabolic imaging modalities has promise to improve treatment. This article reviews current imaging techniques and touches on the evolving technologies being used for detection and follow-up of prostate cancer.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23122036     DOI： 10.1016/j.rcl.2012.08.004

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN： 0033-8389            Impact factor:   2.303


  11 in total

Review 1.  Clinical oncologic applications of PET/MRI: a new horizon.

Authors:  Sasan Partovi; Andres Kohan; Christian Rubbert; Jose Luis Vercher-Conejero; Chiara Gaeta; Roger Yuh; Lisa Zipp; Karin A Herrmann; Mark R Robbin; Zhenghong Lee; Raymond F Muzic; Peter Faulhaber; Pablo R Ros
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-03-20

Review 2.  Multiparametric MRI in prostate cancer management.

Authors:  Linda M Johnson; Baris Turkbey; William D Figg; Peter L Choyke
Journal:  Nat Rev Clin Oncol       Date:  2014-05-20       Impact factor: 66.675

Review 3.  Spatial Tracking of Targeted Prostate Biopsy Locations: Moving Towards Effective Focal Partial Prostate Gland Ablation with Improved Treatment Planning.

Authors:  Steven Sidelsky; Shaan Setia; Srinivas Vourganti
Journal:  Curr Urol Rep       Date:  2017-10-18       Impact factor: 3.092

4.  Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.

Authors:  Oluwaseun A Odewole; Funmilayo I Tade; Peter T Nieh; Bital Savir-Baruch; Ashesh B Jani; Viraj A Master; Peter J Rossi; Raghuveer K Halkar; Adeboye O Osunkoya; Oladunni Akin-Akintayo; Chao Zhang; Zhengjia Chen; Mark M Goodman; David M Schuster
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-04-18       Impact factor: 9.236

5.  Propionic Acid-Based PET Imaging of Prostate Cancer.

Authors:  Zhanwen Zhang; Shaoyu Liu; Hui Ma; Xianhong Xiang; Dahong Nie; Ping Hu; Ganghua Tang
Journal:  Mol Imaging Biol       Date:  2021-04-19       Impact factor: 3.488

Review 6.  Advances in prostate cancer imaging.

Authors:  Matthew R Tangel; Ardeshir R Rastinehad
Journal:  F1000Res       Date:  2018-08-24

7.  Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): a prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer.

Authors:  Sola Adeleke; Arash Latifoltojar; Harbir Sidhu; Myria Galazi; Taimur T Shah; Joey Clemente; Reena Davda; Heather Ann Payne; Manil D Chouhan; Maria Lioumi; Sue Chua; Alex Freeman; Manuel Rodriguez-Justo; Anthony Coolen; Sachin Vadgama; Steve Morris; Gary J Cook; Jamshed Bomanji; Manit Arya; Simon Chowdhury; Simon Wan; Athar Haroon; Tony Ng; Hashim Uddin Ahmed; Shonit Punwani
Journal:  BMC Med Imaging       Date:  2019-11-15       Impact factor: 1.930

Review 8.  Multiparametric ultrasound in the detection of prostate cancer: a systematic review.

Authors:  Arnoud Postema; Massimo Mischi; Jean de la Rosette; Hessel Wijkstra
Journal:  World J Urol       Date:  2015-03-12       Impact factor: 4.226

9.  Transperineal ultrasound-guided 12-core prostate biopsy: an extended approach to diagnose transition zone prostate tumors.

Authors:  Ming-Hua Yao; Li-Ling Zou; Rong Wu; Le-Hang Guo; Guang Xu; Juan Xie; Pei Li; Shuai Wang
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

10.  EpCAM Expression in Lymph Node and Bone Metastases of Prostate Carcinoma: A Pilot Study.

Authors:  Anna K Campos; Hilde D Hoving; Stefano Rosati; Geert J L H van Leenders; Igle J de Jong
Journal:  Int J Mol Sci       Date:  2016-09-29       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.